Viewing Study NCT06552559


Ignite Creation Date: 2025-12-24 @ 2:53 PM
Ignite Modification Date: 2026-02-22 @ 5:09 PM
Study NCT ID: NCT06552559
Status: RECRUITING
Last Update Posted: 2024-08-14
First Post: 2024-08-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma
Sponsor: Samsung Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Lymphoma Recurrent View
None B-cell Lymphoma Refractory View
None CNS Metastases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Hodgkin B-cell lymphoma View
None Secondary CNS involvement View
None Selinexor View
None ICE View